LAURA KEITH: Open Payments
NPI 1881652683 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$255 in 16 payments from 10 companies in 2025. Trend: 2023 $127 · 2024 $76 · 2025 $255
Food & beverage: $255
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $77 |
| Amgen Inc. | 3 | $45 |
| KYOWA KIRIN, INC. | 1 | $23 |
| Medtronic, Inc. | 1 | $21 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $19 |
| Abbott Laboratories | 1 | $14 |
| Daiichi Sankyo Inc. | 1 | $14 |
| Eisai Inc. | 1 | $14 |
| Almatica Pharma LLC | 1 | $14 |
| Xeris Pharmaceuticals, Inc. | 1 | $14 |
Products named: MOUNJARO, KISUNLA, OTEZLA, CRYSVITA, SYMPLICITY G3, JOURNAVX, FREESTYLE LIBRE 3, INJECTAFER.
Industry payments across MO — which companies pay providers there.
